Skip to main content
. 2023 Oct 31;45:e20220576. doi: 10.47626/2237-6089-2022-0576

Table 3. Psychotropic drugs most used by MDD, BD, SCZ, and GAD patients.

Psychotropic drug, n (%) MDD (n = 41) BD (n = 58) SCZ (n = 53) GAD (n = 39) p-value* p-value
Fluoxetine 26 (63.0) 7 (12.0) 7 (13.0) 21 (54.0) < 0.001 < 0.001
Amitriptyline 14 (34.0) 0 (0.0) 8 (15.0) 4 (10.0) < 0.001 < 0.001
Clonazepam 13 (32.0) 13 (22.0) 10 (19.0) 4 (10.0) 0.12 0.2
Lithium 9 (22.0) 24 (41.0) 4 (7.5) 1 (2.6) < 0.001 < 0.001
Diazepam 5 (12.0) 1 (1.7) 2 (3.8) 2 (5.1) 0.2 0.2
Valproate 3 (7.3) 31 (53.0) 13 (25.0) 3 (7.7) < 0.001 < 0.001
Risperidone 4 (9.8) 21 (36.0) 9 (17.0) 4 (10.0) 0.002 0.004
Quetiapine 0 (0.0) 12 (21.0) 0 (0.0) 2 (5.1) < 0.001 < 0.001
Clozapine 1 (2.4) 8 (14.0) 39 (74.0) 0 (0.0) < 0.001 < 0.001
Haloperidol 4 (9.8) 1 (1.7) 4 (7.5) 5 (13.0) 0.14 0.2
Paroxetine 1 (2.4) 2 (3.4) 0 (0.0) 4 (10.0) 0.066 0.11
Sertraline 4 (9.8) 4 (6.9) 2 (3.8) 4 (10.0) 0.6 0.6
Others 16 (39.0) 27 (47.0) 15 (28.0) 14 (36.0) 0.3 0.3

BD = bipolar disorder; GAD = generalized anxiety disorder; MDD = major depressive disorder; SCZ = schizophrenia

* Pearson’s chi-square test, Fisher’s exact test; False discovery rate corrected for multiple testing.